Most metastatic lymph nodes in patients with prostate cancer go undetected by current imaging techniques and limited pelvic lymph node dissection (PLND), as they are small and located in difficult-to-reach areas. As the only current alternative is an extended PLND, the search for more accurate imaging techniques continues.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Hövels, A. M. et al. The diagnostic accuracy of CT and MRI in the staging of pelvic lymph nodes in patients with prostate cancer: a meta-analysis. Clin. Radiol. 63, 387–395 (2008).
Thoeny, H. C. et al. Metastases in normal-sized pelvic lymph nodes: detection with diffusion-weighted MR imaging. Radiology 273, 125–135 (2014).
Birkhauser, F. D. et al. Combined ultrasmall superparamagnetic particles of iron oxide–enhanced and diffusion-weighted magnetic resonance imaging facilitates detection of metastases in normal-sized pelvic lymph nodes of patients with bladder and prostate cancer. Eur. Urol. 64, 953–960 (2014).
Fortuin, A. S. et al. Value of PET/CT and MR lymphography in treatment of prostate cancer patients with lymph node metastases. Int. J. Radiat. Oncol. Biol. Phys. 84, 712–718 (2012).
Heesakkers, R. A. et al. Prostate cancer: detection of lymph node metastases outside the routine surgical area with ferumoxtran-10-enhanced MR imaging. Radiology 251, 408–414 (2009).
Van den Bergh, L. et al. Final analysis of a prospective trial on functional imaging for nodal staging in patients with prostate cancer at high risk for lymph node involvement. Urol. Oncol. http://dx.doi.org/10.1016/j.urolonc.2014.11.008 (2015).
Meijer, H. J. M. et al. Geographical distribution of lymph node metastases on MR lymphography in prostate cancer patients. Radiot. Oncol. 106, 59–63 (2013).
Heesakkers, R. A. et al. MRI with a lymph-node-specific contrast agent as an alternative to CT scan and lymph-node dissection in patients with prostate cancer: a prospective multicohort study. Lancet Oncol. 9, 850–856 (2008).
Afshar-Oromieh, A. et al. Comparison of PET imaging with a (68)Ga-labelled PSMA ligand and (18)F-choline-based PET/CT for the diagnosis of recurrent prostate cancer. Eur. J. Nucl. Med. Mol. Imaging 41, 11–20 (2014).
Yu, C. Y., Desai, B., Ji, L., Groshen, S. & Jadvar, H. Comparative performance of PET tracers in biochemical recurrence of prostate cancer: a critical analysis of literature. Am. J. Nucl. Med. Mol. Imaging. 4, 580–601 (2014).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing financial interests.
PowerPoint slides
Rights and permissions
About this article
Cite this article
Barentsz, J., Thoeny, H. Can imaging accurately diagnose lymph node involvement?. Nat Rev Urol 12, 313–315 (2015). https://doi.org/10.1038/nrurol.2015.91
Published:
Issue Date:
DOI: https://doi.org/10.1038/nrurol.2015.91
This article is cited by
-
PET imaging for lymph node dissection in prostate cancer
World Journal of Urology (2017)
-
Prostatadiagnostik nach PI‑RADS 2.0
Der Radiologe (2017)